Efficacy and safety of umeclidinium plus vilanterol versus tiotropium, vilanterol, or umeclidinium monotherapies over 24 weeks in patients with chronic obstructive pulmonary disease: results from two multicentre, blinded, randomised controlled trials

✍ Scribed by Decramer, Marc; Anzueto, Antonio; Kerwin, Edward; Kaelin, Thomas; Richard, Nathalie; Crater, Glenn; Tabberer, Maggie; Harris, Stephanie; Church, Alison

• Book ID: 122172603
• Publisher: Elsevier
• Year: 2014
• Tongue: English
• Weight: 272 KB
• Volume: 2
• Category: Article
• ISSN: 2213-2600
• DOI: 10.1016/S2213-2600(14)70065-7